• Exchange: LSE EuropeQS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

ORNBV:LI

26.530 EUR 0.240 0.90%

As of 11:29:34 ET on 07/29/2014.

Snapshot for Orion OYJ (ORNBV)

Open: 27.040 Day's Range: 26.430 - 27.265 Volume: 3,397
Previous Close: 26.770 52wk Range: 17.470 - 28.205 1-Yr Rtn: +46.37%

Stock Chart for ORNBV

No chart data available.
  • ORNBV:LI 26.555
  • 1D
  • 1M
  • 1Y
26.770
Interactive ORNBV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ORNBV

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 18.3981
Relative P/E vs. UKX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 1.4420
Est. PEG Ratio -
Market Cap (M EUR) 3,754.76
Shares Outstanding (M) 99.89
30 Day Average Volume 3,114
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 4.71%
Cash Dividend (EUR) 1.2500
Dividend Ex-Date 03/26/2014
5 Year Dividend Growth -
Next Earnings Announcement 07/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ORNBV

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ORNBV

Orion Oyj develops and manufactures pharmaceuticals and diagnostic kits. The Company produces hormone therapies and drugs to treat central nervous system disorders, cardiovascular diseases and urological disorders, and in vitro diagnostic kits used in doctor's offices and small laboratories.

Hannu SyrjaenenChairmanJukka YlppoVice Chairman
Timo LappalainenPresident/CEOJari KarlsonChief Financial Officer
More Company Profile & Key Executives for ORNBV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil